Intbox Ventures, LLC’s Post

The “Placental Tissue Amendment Bill”, Part of SB 0199, Passed by Utah State Legislature - https://lnkd.in/e6scAeg4 The “Placental Tissue Amendment Bill“, part of SB 0199, recently passed by the Utah State Legislature, introduces specific requirements for healthcare providers administering treatments involving placental stem cells. The key focus of this bill is to ensure that patients receive adequate disclosures regarding the nature of the treatment, particularly if it involves stem cell therapy that hasn’t been approved by the United States Food and Drug Administration (FDA). Read more at: https://lnkd.in/e6scAeg4 #placenta #stemcells #celltherapy

I am thrilled to share our latest research on stem cell therapy and its promising efficacy on chronic liver disease patients. This umbrella review includes 28 systematic reviews. The meta-analysis showcased a notable improvement in survival rates with a pooled RR of 1.487 (95% CI: 1.281 to 1.727). In non-randomized studies, albumin levels exhibited an SMD of 0.786 (95% CI: 0.368 to 1.204), indicating positive therapeutic effects. For ALT, the meta-analysis revealed a decrease in levels with an SMD of -0.499 (95% CI: -0.834 to -0.164), and for AST, an overall SMD of -0.362 (95% CI: -0.659 to -0.066) was observed, suggesting hepatoprotective effects. Link: https://lnkd.in/eqzYmm7f

Stem cell therapy is revolutionizing diabetes care by targeting the root cause—regenerating insulin-producing cells in the pancreas and improving insulin sensitivity. This innovative approach offers hope for better blood sugar control, reducing insulin dependence, and even preventing complications like nerve damage and kidney failure. As research continues, stem cells may hold the key to restoring normal metabolic function and transforming the lives of diabetes patients. 🔗 Click the link in our bio to learn more about how stem cell therapy is changing the future of diabetes treatment. International Stem Cell Institute 📞 (941)-867-7224 🌐 https://lnkd.in/dxCJCXmc #stemcells #stemcellresearch #stemcelltherapy #regenerativemedicine #cellulartherapy #stemcelltransplant

Research: Therapeutic potential of human umbilical cord-derived mesenchymal stem cells in Crohn’s disease. https://lnkd.in/eaMs8nW5

iPS Cell-based Therapy Induced pluripotent stem cell (iPSC) therapy represents a major breakthrough in regenerative medicine, offering potential treatments for a range of diseases by reprogramming adult cells into embryonic-like stem cells. These iPSCs can differentiate into virtually any cell type, providing a unique platform for generating patient-specific cells that can replace damaged tissue or cells affected by disease. One of the most compelling applications of iPSC therapy is in the treatment of degenerative diseases such as Parkinson's disease, where iPSCs can be differentiated into dopaminergic neurons and transplanted into patients to replace lost neurons. Similarly, for diseases such as diabetes, iPSCs can be converted into pancreatic beta cells to restore insulin production. Advantages of iPSC-based therapies include their autologous nature, which reduces the risk of immune rejection, and the potential to provide an unlimited source of any type of human cell needed for treatment. However, challenges remain, such as ensuring the safety of iPSC-derived cells, preventing their potential tumorigenicity, and optimizing cell differentiation protocols. Ongoing research and clinical trials continue to refine methods for the generation and application of iPSCs, aiming to fully realize the therapeutic potential of this innovative approach, which will hopefully provide new treatments for previously untreatable diseases. References [1] Jun Takahashi, Regen Ther 2020 (10.1016/j.reth.2020.06.002) [2] Shin Enosawa, J Clin Med 2022 (10.3390/jcm11237030) #iPSC #RegenerativeMedicine #StemCellTherapy #ParkinsonsTreatment #DiabetesCare #CellularTherapy #BiomedicalResearch #HealthInnovation

🔬📚 Thrilled to announce our latest publication in Cell Death & Disease! 🎉 Delve into our latest research findings on the role of DMRTA2 in glioblastoma stem cells and neovascularization. Click the link below to read our paper! #Science #Research #CancerStemCell #Disease #Glioblastoma

📚 Excited to share the publication of my first book chapter! Explore the fascinating world of immune evasive stem cell islets here: https://lnkd.in/dCz5HWVP This is part of the “Pluripotent Stem Cell Therapy for Diabetes” book, a collaborative effort with colleagues worldwide. Together, we're sharing insights on beta cell replacement #Research #Diabetes #stemcell #Betacell

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant A Phase II Study on Lenalidomide and Dexamethasone for Relapsed Multiple Myeloma Background Allogeneic stem cell transplant is currently the only potential cure for multiple myeloma (MM), but most patients will relapse. This study aimed to explore the effectiveness and safety of lenalidomide and dexamethasone (Len/Dex) followed by donor lymphocyte infusions (DLIs) in patients who relapsed after transplant. Methods Eligible patients aged 18-65 with relapsed MM after transplant received: Six cycles of Len/Dex Three doses of DLIs at intervals of 6 weeks Bone marrow tests were conducted to monitor disease status. The main goal was to measure progression-free survival (PFS) at 2 years after treatment. Results A total of 22 patients participated, with 62% having high-risk features. Key findings include: Median follow-up: 5.3 years PFS: 26.5% Overall survival (OS): 69.2% Response rates: 9.1% complete remission, 50% very good partial response Only 18.2% experienced moderate/severe chronic graft-versus-host disease (GVHD) No unexpected side effects were noted, and a positive link was found between responses to Len/Dex and DLIs. Conclusions This study indicates that Len/Dex followed by DLIs is a safe and feasible option for treating relapsed MM after transplant. Future studies may explore stronger induction therapies and higher DLI doses. Clinical Trial Importance Clinical trials are essential for developing effective treatments. Our AI-driven platform, DocSym, helps integrate clinical protocols and research into a user-friendly resource for healthcare providers. Streamlining Patient Care In today’s healthcare landscape, efficiency is vital. Our mobile applications facilitate scheduling, treatment monitoring, and telemedicine, enhancing patient management and expanding digital services. Enhancing Clinic Operations By leveraging AI, clinics can improve workflows, enhance patient outcomes, and reduce paperwork. Discover how we can assist you at aidevmd.com. https://lnkd.in/g2RxwbvA #ClinicalTrials #AIinHealthcare #MedicalAI #HealthTech #DigitalHealth #PatientCareAI #AIResearch #MedicalInnovation #BioTech #AIforGood #HealthcareData #AIinMedicine #PharmaAI #ClinicalData #HealthAI #AIHealthSolutions #PrecisionMedicine #AIandHealth #ClinicalAnalytics #AIDiagnostics

Did you see this fascinating piece of legislation that was just passed in Utah? The “Placental Tissue Amendment Bill”, Part of SB 0199, Defines Disclosures & Consent Practices for Stem Cell Therapies Offered by Medical Providers - https://lnkd.in/ecRTzh-w The “Placental Tissue Amendment Bill“, part of SB 0199, recently passed by the Utah State Legislature, introduces specific requirements for healthcare providers administering placental stem cell treatments. The key focus of this bill is to ensure that patients receive adequate disclosures regarding the nature of the treatment, particularly if it involves stem cell therapy that hasn’t been approved by the United States Food and Drug Administration (FDA). Read more at: https://lnkd.in/ecRTzh-w What are your thoughts on this bill? Share them in comments below. #placenta #stemcells #celltherapy

Rheumatoid Arthritis and Stem Cell Miracles at Thailand’s Vega Clinic: A Patient’s Guide   For individuals battling rheumatoid arthritis, finding effective treatment options can be a daunting journey. However, Thailand's Vega Clinic has emerged as a beacon of hope, offering innovative stem cell therapies that have shown promise in alleviating symptoms and improving quality of life for patients. Here's a guide for patients considering this revolutionary approach to managing rheumatoid arthritis.   1. Understanding Rheumatoid Arthritis Learn about the basics of rheumatoid arthritis, including its symptoms, causes, and impact on daily life. Understanding your condition is the first step towards exploring potential treatment options.   2. Exploring Stem Cell Therapy Delve into the concept of stem cell therapy and how it works in the context of rheumatoid arthritis treatment. Understand the potential benefits, risks, and limitations associated with this innovative approach.   3. Navigating Treatment at Vega Clinic Get acquainted with Thailand's Vega Clinic and the specialized stem cell therapies offered for rheumatoid arthritis. Learn about the clinic's facilities, medical team, and patient support services.   4. Preparing for Treatment Understand the pre-treatment evaluation process, including medical assessments and consultations with healthcare professionals. Prepare mentally and physically for the journey ahead, including travel arrangements and accommodation in Thailand.   5. Post-Treatment Care and Follow-Up Explore the importance of post-treatment care and follow-up appointments to monitor progress, address any concerns, and optimize long-term outcomes. Embrace lifestyle modifications and self-care practices to support your body's healing process.   As you embark on this journey with Vega Clinic's stem cell therapies for rheumatoid arthritis, remember that you are not alone. By equipping yourself with knowledge, support, and a positive mindset, you can take proactive steps towards managing your condition and improving your quality of life. Together, let's explore the potential of stem cell miracles in the fight against rheumatoid arthritis.   #RheumatoidArthritis #StemCellTherapy #VegaStemCellClinic #PlacidWay #MedicalTourism